Leonard Rozamus
Director Técnico/Científico/I+D en THESEUS PHARMACEUTICALS, INC. .
Perfil
Leonard Rozamus is the founder of Rozamus & Associates, Inc. He currently holds the position of Senior Vice President-Technical Operations at Theseus Pharmaceuticals, Inc. Previously, he worked as Senior Director-Manufacturing Operations at ARIAD Pharmaceuticals, Inc. Mr. Rozamus has a graduate degree from the University of Virginia and an undergraduate degree from The College of William & Mary.
Cargos activos de Leonard Rozamus
| Empresas | Cargo | Inicio |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
| Rozamus & Associates, Inc. | Fundador | - |
Antiguos cargos conocidos de Leonard Rozamus.
| Empresas | Cargo | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Leonard Rozamus.
| University of Virginia | Graduate Degree |
| The College of William & Mary | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
| Rozamus & Associates, Inc. |
- Bolsa de valores
- Insiders
- Leonard Rozamus
